VIR - Vir Biotechnology Inc
IEX Last Trade
8.25
-0.050 -0.606%
Share volume: 552,855
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$8.30
-0.05
-0.60%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-03 | 2023-02-28 | 2023-05-08 | 2023-08-04 | 2023-11-03 | 2024-02-26 | 2024-05-03 | 2024-08-01 | |
| Assets | |||||||||
| Total Assets | 2.696 B | 2.802 B | 2.666 B | 2.244 B | 2.045 B | 1.919 B | 1.794 B | 1.670 B | |
| Current Assets | 2.414 B | 2.519 B | 2.359 B | 1.946 B | 1.769 B | 1.588 B | 1.213 B | 1.206 B | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 54.180 M | 86.740 M | 97.602 M | 85.736 M | 59.430 M | 52.549 M | 49.999 M | 40.729 M | |
| Short Term Investments | 76.981 M | 118.632 M | 116.185 M | 99.267 M | 70.255 M | 62.402 M | 53.926 M | 45.097 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.324 B | 2.370 B | 2.231 B | 1.834 B | 1.686 B | 1.513 B | 1.146 B | 1.147 B | |
| Total Non-current Assets | 282.354 M | 283.011 M | 307.302 M | 297.542 M | 275.719 M | 330.834 M | 580.872 M | 463.815 M | |
| Property Plant Equipment | 100.226 M | 105.609 M | 103.758 M | 104.126 M | 99.309 M | 96.018 M | 92.477 M | 66.063 M | |
| Other Assets | 6.209 M | 14.570 M | 16.554 M | 16.853 M | 14.720 M | 12.409 M | 12.495 M | 13.292 M | |
| Intangible Assets | 32.888 M | 32.755 M | 32.622 M | 25.590 M | 25.457 M | 22.565 M | 22.465 M | 18.899 M | |
| Goodwill | 16.937 M | 16.937 M | 16.937 M | 16.937 M | 16.937 M | 16.937 M | 16.937 M | 16.937 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.696 B | 2.802 B | 2.666 B | 2.244 B | 2.045 B | 1.919 B | 1.794 B | 1.670 B | |
| Total liabilities | 546.115 M | 724.125 M | 695.179 M | 433.666 M | 369.810 M | 328.824 M | 246.613 M | 235.885 M | |
| Total current liabilities | 308.203 M | 511.029 M | 485.288 M | 225.623 M | 165.050 M | 175.407 M | 94.068 M | 96.412 M | |
| Accounts Payable | 2.722 M | 6.422 M | 12.149 M | 12.362 M | 3.627 M | 6.334 M | 7.114 M | 4.389 M | |
| Other liabilities | 92.531 M | 86.006 M | 85.133 M | 90.228 M | 90.641 M | 41.744 M | 43.374 M | 44.455 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 92.531 M | 86.006 M | 85.133 M | 90.228 M | 90.641 M | 41.744 M | 43.374 M | 44.455 M | |
| Minority interest | 0.000 | 0.000 | 44.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 2.150 B | 2.078 B | 1.971 B | 1.810 B | 1.675 B | 1.590 B | 1.547 B | 1.434 B | |
| Common stock | 132.730 M | 133.168 M | 133.553 M | 134.059 M | 134.290 M | 134.622 M | 135.281 M | 136.234 M | |
| Retained earnings | 478.840 M | 377.237 M | 236.337 M | 41.562 M | -121.851 M | -237.824 M | -303.100 M | -441.478 M |